| Members Present: Sen. Allen M. Christensen, Chair Rep. Brad M. Daw, Chair Sen. David G. Buxton Sen. Luz Escamilla Sen. Evan J. Vickers Rep. Stewart E. Barlow Rep. Jennifer Dailey-Provost Rep. Steve Eliason Rep. Sandra Hollins Rep. Brian S. King Rep. Karianne Lisonbee Rep. Kelly B. Miles | Rep. Paul Ray Rep. Rex P. Shipp Rep. Robert M. Spendlove Rep. Norman K. Thurston Rep. Raymond P. Ward Staff Present: Mark D. Andrews, Policy Analyst Karin M. Rueff, Policy Analyst Daniel M. Cheung, Associate General Counsel Ericka A. Evans, Associate General Counsel Christopher Williams, Associate General Counsel Amy Hawkes, Administrative Assistant |
||
|
Note: A copy of related materials and an audio recording of the
meeting can be found at www.le.utah.gov.
|
| Chair Daw called the meeting to order at 1:22 p.m. |
| 1. Committee Business |
| MOTION: Rep. Ray moved to approve the minutes of the June 16, 2020, meeting. The motion passed with a vote of 13-0-4. | |||
| Yeas - 13 | Nays-0 | Abs-4 | |
| Rep. S. Barlow Sen. D. Buxton Sen. A. Christensen Rep. J. Dailey-Provost Rep. B. Daw Rep. S. Hollins Rep. B. King Rep. K. Miles Rep. P. Ray Rep. R. Shipp Rep. R. Spendlove Rep. N. Thurston Rep. R. Ward | Rep. S. Eliason Sen. L. Escamilla Rep. K. Lisonbee Sen. E. Vickers |
| 2. COVID-19: An Update |
| 5.3 Unified Response Overview (Source: Utah Department of Health) |
| Rich Saunders, Interim Executive Director, Utah Department of Health, discussed a unified response plan for COVID-19 and answered committee questions. |
| 5.4 Case and Death Chart (Source: Utah Department of Health) |
| Dr. Angela Dunn, State Epidemiologist, Utah Department of Health, discussed the state's response to COVID-19 and answered committee questions. |
| Nathan Checketts, Testing Coordinator, Utah Department of Health, updated the committee on COVID-19 testing. |
| Heather Borski, Director, Division of Disease Control and Prevention, Utah Department of Health, discussed COVID-19 mobile testing, discussed the Utah Mobile Health Lab, and answered committee questions. |
| 3. Health Insurance Premium Subsidies |
| 4.1 H.B. 6003, Premium Subsidy Amendments (J. Dunnigan) |
| Rep. Jim Dunnigan presented H.B. 6003, "Premium Subsidy Amendments." |
| MOTION: Rep. Daw moved that the committee recommend H.B. 6003, "Premium Subsidy Amendments," as worthy of being passed by the House during the 2020 Sixth Special Session of the Legislature. The motion passed with a vote of 17-0-0. | |||
| Yeas - 17 | Nays-0 | Abs-0 | |
| Rep. S. Barlow Sen. D. Buxton Sen. A. Christensen Rep. J. Dailey-Provost Rep. B. Daw Rep. S. Eliason Sen. L. Escamilla Rep. S. Hollins Rep. B. King Rep. K. Lisonbee Rep. K. Miles Rep. P. Ray Rep. R. Shipp Rep. R. Spendlove Rep. N. Thurston Sen. E. Vickers Rep. R. Ward |
| 4. Medical Cannabis |
| Sen. Vickers updated the committee on medical cannabis policy and answered committee questions. |
| Amber Brown, Senior Policy Analyst, Utah Department of Agriculture and Food, introduced Cody James, Manager, Industrial Hemp and Medical Cannabis Program, Utah Department of Agriculture and Food. |
| Cody James provided an update on medical cannabis production levels and licensing issues and answered committee questions. |
| 6.5 Proposed Statutory Changes: Medical Cannabis Program (Source: Utah Department of Agriculture and Food) |
| Amber Brown presented information on proposed statutory changes to the Medical Cannabis Program and answered committee questions. |
| 6.6 Medical Cannabis Report (Source: Utah Department of Health) |
| Rich Oborn, Director, Center for Medical Cannabis, Utah Department of Health, updated the committee on the Medical Cannabis Program and answered committee questions. |
| 5. Department of Health |
| 2.1 S.B. 6006, Department of Health Modifications (A. Christensen) |
| Chair Christensen presented S.B. 6006, "Department of Health Modifications," and answered committee questions. |
| 2.2 Department of Health Modifications Amendments (K. Miles) |
| Chair Christensen explained a draft amendment to S.B. 6006 prepared and distributed by Rep. Miles (Amendment X, August 19, 2020, 2:31 PM). |
| Michelle McOmber, CEO, Utah Medical Association, spoke to S.B. 6006, "Department of Health Modifications." |
| 6. Pharmaceutical Reporting |
| 3.1 H.B. 6011 Pharmaceutical Reporting Amendments (P. Ray) |
| Rep. Ray presented H.B. 6011, "Pharmaceutical Reporting Amendments." |
| 7. Opioids - Post-Surgery Prescriptions |
| 7.1 DRAFT LEGISLATION: Controlled Substance Amendments (Ward) |
| Rep. Ward presented draft legislation, "Controlled Substance Amendments." |
| MOTION: Rep. Ward moved that the committee recommend draft legislation "Controlled Substance Amendments" (2021FL-0226/003). The motion passed with a vote of 16-0-1. | |||
| Yeas - 16 | Nays-0 | Abs-1 | |
| Rep. S. Barlow Sen. D. Buxton Sen. A. Christensen Rep. J. Dailey-Provost Rep. B. Daw Sen. L. Escamilla Rep. S. Hollins Rep. B. King Rep. K. Lisonbee Rep. K. Miles Rep. P. Ray Rep. R. Shipp Rep. R. Spendlove Rep. N. Thurston Sen. E. Vickers Rep. R. Ward | Rep. S. Eliason |
| 8. Ethical Drug Framework |
| Rep. Thurston proposed that a framework be developed for determining which drugs should be available without a prescription. |
| Andy Janes, Senior Officer, Foreign Policy and Diplomacy Services, Consulate General of Canada, explained the criteria used by Canada to determine whether a drug requires a prescription for dispensing. |
| MOTION: Rep. Dailey-Provost moved to adjourn. The motion passed with a vote of 13-0-4. | |||
| Yeas - 13 | Nays-0 | Abs-4 | |
| Rep. S. Barlow Sen. D. Buxton Sen. A. Christensen Rep. J. Dailey-Provost Rep. B. Daw Sen. L. Escamilla Rep. B. King Rep. K. Lisonbee Rep. K. Miles Rep. P. Ray Rep. R. Shipp Rep. R. Spendlove Rep. N. Thurston | Rep. S. Eliason Rep. S. Hollins Sen. E. Vickers Rep. R. Ward |
| Chair Christensen adjourned the meeting at 4:09 p.m. |